-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | -1.700% | -13.065% | -13.065% | -7.487% | -38.214% | -23.026% | - |
Burcon Nutrascience Corp. | 8.410% | 10.224% | 10.932% | -58.559% | 32.184% | -87.979% | -93.391% |
Larimar Therapeutics Inc. | 0.950% | 6.533% | 6.533% | -75.349% | -43.011% | -11.667% | -83.866% |
News

Broadcom, Nvidia, and AMD Could Help This Unstoppable ETF Turn $250,000 Into $1 Million in 10 Years
Nvidia (NASDAQ: NVDA) CEO Jensen Huang thinks that data center operators will spend $1 trillion every year on chips and infrastructure by 2028 to meet growing demand for computing capacity from

Should You Invest $1,000 in Taiwan Semiconductor Stock Today?
During the month of May, stocks started exhibiting some much-needed resilience. The S&P 500 and Nasdaq Composite indexes rose by 5% and 8%, respectively.
After bearing the brunt of precipitous

2 No-Brainer Stocks I'd Buy Right Now Without Hesitation
Buying stocks of companies benefiting from long-term industry trends can help you identify rewarding investment opportunities. The following companies are serving growing demand in the semiconductor